Acetanilide
Specifications
103-84-4CAS Number
203-150-7EC Number
N-phenylacetamideIUPAC Name
C8H9NOChemical Formula
135.16 g/molMolecular Weight
acetanilide; N-Phenylacetamide; 103-84-4; Antifebrin; N-Acetylaniline; Acetanilid; Acetamidobenzene; Acetanil; Acetylaniline; Phenalgene; Acetamide, N-phenyl-; Acetylaminobenzene; Acetic acid anilide; Acetoanilide; Phenalgin; Aniline, N-acetyl-; USAF EK-3; Benzenamine, N-acetyl-; Acetanilidum; Antifebrinum; NSC-7636; SP86R356CC; NSC-203231; CHEBI:28884; RefChem:6369; 203-150-7; 695-031-5; N-acetylarylamine; N-Acetylaminobenzene; AN [Analgesic]; NSC 7636; MFCD00008674; Ethananilide; N-Phenyl-acetamide; DTXSID2022543; Acetanilide (Antifebrin); Acetanilide (Acetylaniline); NSC7636; N-Phenylacetamide;N-Phenylacetamide; NCGC00091326-01; DTXCID602543; N-Phenylacetamide (Acetanilide); Caswell No. 003E; Acetamide, N-(phenyl-13C6)-; N-phenylethanamide; Acetanilide [NF]; CAS-103-84-4; SMR001306799; Acetic acid amide, N-phenyl-; CCRIS 4452; HSDB 2665; EINECS 203-150-7; UNII-SP86R356CC; AI3-01045; PhNHAc; N-phenyl acetamide; Acetanilide, 99%; N-Acetyl-benzenamine; Acetanilide M.P. RS; Spectrum_000178; AZOBENZENE_met003; ACETANILIDE [MI]; Spectrum2_001434; Spectrum3_000935; Spectrum4_001034; Spectrum5_000989; ACETANILIDE [HSDB]; WLN: 1VMR; ACETANILIDE [VANDF]; ACETANILIDUM [HPUS]; Acetaminophen EP impurity D; ACETANILIDE [MART.]; SCHEMBL19602; SCHEMBL24681; SCHEMBL50031; SCHEMBL96556; SCHEMBL97108; ACETANILIDE [USP-RS]; ACETANILIDE [WHO-DD]; KBioGR_001587; KBioSS_000658; MLS002207284; MLS002415707; orb134314; DivK1c_000073; SCHEMBL834716; SPECTRUM1501173; SPBio_001568; CHEMBL269644; orb2893746; SCHEMBL4628395; SCHEMBL4628415; SCHEMBL5158336; Acetanilide, LR, >=98.5%; HMS500D15; KBio1_000073; KBio2_000658; KBio2_003226; KBio2_005794; KBio3_001970; NINDS_000073; ACETIC ACID,AMIDE,N-PHENYL; HMS1921N07; HMS2092J11; HMS2234E18; HMS3374L04; HMS3651D07; Pharmakon1600-01501173; Tox21_111113; Tox21_200925; CCG-38984; EBC-00534; MSK001759; NSC757879; SBB040833; STK046402; AKOS000121114; Tox21_111113_1; FA17107; MSK001759-100A; NSC-757879; Acetanilide, NIST(R) SRM(R) 141d; IDI1_000073; ACETANILIDE MELTING POINT STANDARD; MSK001759-1000A; NCGC00091326-02; NCGC00091326-03; NCGC00091326-04; NCGC00091326-06; NCGC00258479-01; AS-13389; ST040202; SBI-0051673.P002; A3272; CS-0010112; NS00003596; PARACETAMOL IMPURITY D [EP IMPURITY]; SW220057-1; EN300-26568; Acetanilide Solution in Acetonitrile, 100ug/mL; C07565; D72485; AB00052235_07; AB00052235_08; Acetanilide Solution in Acetonitrile, 1000ug/mL; Acetanilide, purified by sublimation, >=99.9%; Acetanilide, puriss. p.a., >=99.5% (CHN); AH-034/32461060; F236729; Q421761; SR-05000001777; SR-05000001777-1; BRD-K11094367-001-04-4; BRD-K11094367-001-09-3; BRD-K11094367-001-10-1; Z27782600; F0808-0907; Paracetamol EP Impurity D; Acetaminophen Related Compound D; Acetanilide, zone-refined, purified by sublimation, >=99.95%; Acetanilide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard; InChI=1/C8H9NO/c1-7(10)9-8-5-3-2-4-6-8/h2-6H,1H3,(H,9,10; 137020-73-6; Acetanilide melting point standard, Pharmaceutical Secondary Standard; Certified Reference MaterialSynonyms